Inactive Instrument
Quotes GENFIT Euronext Paris
Stocks
FR0004163111
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 07-03 | Genfit soars on news of U.S. reimbursement for a product | |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Stock exchange
Euronext Paris- €
-
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GNFT | 13.78EUR | -0.58% | 1.75M € | ||
CBOE
| GNFTp | 13.70EUR | -1.30% | 380K € | |
Börse Stuttgart
| XUP | 13.70EUR | -0.58% | 109K € | |
Tradegate
| XUP | 13.80EUR | -0.58% | 10K € | |
Boerse Muenchen
| XUP | 13.76EUR | -0.72% | 6.88K € | |
OTC Markets
| GNFTF | 15.75USD | -3.26% | 6.14K $ | |
CBOE
| 0QT6 | 13.95EUR | -2.38% | 4.84K € | |
Xetra
| XUP | 14.08EUR | -1.81% | 2.77K € | |
Deutsche Boerse AG
| XUP | 13.78EUR | -3.50% | 0 € | |
London S.E.
| 0QT6 | 13.74EUR | -0.72% | 0 € |
Basic data
Market Cap (EUR)
689,888,884
Market Cap (USD)
801,085,174
Net sales (EUR)
71,115,000
Net sales (USD)
82,577,316
Free-Float
86.89 %
Free-Float capitalization (EUR)
599,604,740
Free-Float capitalization (USD)
696,249,032
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 801M | ||
| -2.54% | -2.84% | -1.90% | +14.52% | 48.93B | ||
| -0.40% | +1.03% | +439.20% | +499.20% | 45.01B | ||
| -1.42% | +2.30% | +45.46% | +19.36% | 44.07B | ||
| -1.22% | -2.31% | +12.40% | +71.48% | 40.73B | ||
| +0.53% | -1.36% | +16.04% | +48.23% | 33.52B | ||
| -0.21% | +9.14% | - | - | 17.77B | ||
| -0.35% | -1.56% | +22.59% | +116.19% | 16.5B | ||
| -1.01% | +0.50% | +13.91% | +31.45% | 14.67B | ||
| -1.65% | -1.03% | +77.75% | +37.63% | 13.77B | ||
| Average | -0.92% | +0.53% | +78.18% | +104.76% | 27.58B | |
| Weighted average by Cap. | -1.03% | +0.11% | +94.75% | +122.31% |
Historical Quotes: GENFIT
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- GNFT Stock
- Stock
- Quotes GENFIT
Select your edition
All financial news and data tailored to specific country editions

















